Azithromycin versus penicillin V in the treatment of paediatric patients with acute Streptococcal pharyngitis/tonsillitis

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 15, Issue 9, 1996, Pages 718-724

  O'Doherty, B ^a   Pilfors, G ^b   Quinn, P T ^b   Howard, A ^b   Bradbury, F ^b   Scully, M ^b   Clarke, O ^b   Kiernan, J ^b   Ryan, M F ^b   O'Kelly, P ^b   Williams, P A ^b   Khong, T K ^b   Hamill, J J ^b   Burman, A ^b   Khatri, C P ^b   Agrawal, P ^b   Soares, P ^b   Hughes, I ^b  

^a Merrion Lodge   (Ireland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; PENICILLIN V;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; BACTERIUM CULTURE; CHILD; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PHARYNGITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RECURRENCE RISK; RECURRENT DISEASE; STREPTOCOCCUS; STREPTOCOCCUS PYOGENES; TONSILLITIS; VOMITING;

ADMINISTRATION, ORAL; ADOLESCENT; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; PENICILLIN V; PENICILLINS; PHARYNGITIS; PROSPECTIVE STUDIES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TONSILLITIS; TREATMENT OUTCOME;

EID: 10244221001     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01691958     Document Type: Article

References (23)

1. Bisno AL: Streptococcus pyogenes. In: Mandell GL, Douglas RG, Bennett JE (ed): Principles and practice of infectious diseases. Churchill Livingstone, New York, 1990, p. 519-1528.
2. Wannamaker WL, Rammelkamp CH, Denny FW, Brink WR, Houser HB, Hahn HO: Prophylaxis of acute rheumatic fever by treatment of the preceding streptococcal infection with various amounts of depot penicillin. American Journal of Medicine 1951, 10: 673-679.
3. Bass JW: Antibiotic management of group A streptococcal pharyngotonsillitis. Paediatric Infectious Disease Journal 1991, 10, Supplement: 10-49.
4. Pichichero ME: Explanations and therapies for penicillin failure in streptococcal pharyngitis. Clinical Pediatrics 1992, 31: 642-649.
5. Kim KS, Kaplan EL: Association of penicillin tolerance with failure to eradicate group A streptococci from patients with pharyngitis. Journal of Pediatrics 1985, 107: 642-649.
6. Raz R, Hamburger S, Flatau E: Clindamycin in the treatment of an outbreak of streptococcal pharyngitis in a kibbutz due to beta-lactamase producing organisms. Journal of Chemotherapy 1990, 2: 182-184.
7. Colcher IS, Bass JW: Penicillin treatment of streptococcal pharyngitis. A comparison of schedules and the role of specific counselling. Journal of the American Medical Association 1972, 222: 657-659.
8. Pilot MA, Qin XY: Macrolides and gastrointestinal motility. Journal of Antimicrobial Chemotherapy 1988, 19: 275-276.
9. Pechère JC: The use of macrolides in respiratory tract infections. International Journal of Antimicrobial Agents 1993, 3, Supplement: 53-61.
10. Cockburn J, Gibberd RW, Reid AL, Sanson-Fisher RW: Determinants of non-compliance with short-term antibiotic regimens. British Medical Journal 1987, 295: 814-818.
11. Bright GM, Nagel AA, Bordner J, Desai KA, Dibrino JN, Nowakowska J, Vincent L, Watrous RM, Sciavolino FC: Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-aza-9a-homoerythromycin A derivatives; a new class of macrolide antibiotics, the azalides. Journal of Antibiotics 1988, 41: 1029-1047.
12. Retsema J, Girard A, Schelkly W, Manousos M, Anderson M, Bright G, Borovoy R, Brennan L, Mason R: Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. Antimicrobial Agents and Chemotherapy 1987, 31: 1939-1947.
13. Foulds G, Shepard RM, Johnson RB: The pharmacokinetics of azithromycin in human serum and tissues. Journal of Antimicrobial Chemotherapy 1990, 25, Supplement A: 73-82.
14. Foulds G, Chan KH, Johnson JT, Shepard RM, Johnson RB: Concentrations of azithromycin in human tonsillar tissue. European Journal of Clinical Microbiology & Infectious Diseases 1991, 10: 853-856.
15. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial disk susceptibility tests. Order code M2-A4. NCCLS, Villanova, PA, 1988.
16. Hamill J: Multicentre evaluation of azithromycin and penicillin V in the treatment of acute streptococcal pharyngitis and tonsillitis in children. Journal of Antimicrobial Chemotherapy 1993, 31, Supplement E: 89-94.
17. Weippl G: Multicentre comparison of azithromycin versus erythromycin in the treatment of paediatric pharyngitis/tonsillitis caused by group A streptococci. Journal of Antimicrobial Chemotherapy 1993, 31, Supplement E: 95-101.
18. Bottaro G, Rotolo N, Bonforte S, Bucchieri R, De-Luca P, Ficarra G, Gulino AF, Melillo PA, Nicosia A, Prestifilippo F: Evaluation of the clinical efficacy of azithromycin for acute respiratory infections in children. Clinica Terapeutica 1994, 144: 35-39.
19. Müller O: Comparison of azithromycin versus clarithromycin in the treatment of patients with upper respiratory tract infection. Journal of Antimicrobial Chemotherapy 1993, 31, Supplement E: 137-146.
20. Hooton TM: A comparison of azithromycin and penicillin V for the treatment of streptococcal pharyngitis. American Journal of Medicine 1991, 91, Supplement 3A: 23S-26S.
21. Gatley MS: To be taken as directed. Journal of the Royal College of General Practitioners 1968, 16: 39-44.
22. Bergman AB, Werner RJ: Failure of children to receive penicillin by mouth. New England Journal of Medicine 1963, 268: 1334-1338.
23. Greenberg RN: Overview of patient compliance with medication dosing: a literature review. Clinical Therapeutics 1984, 6: 592-599.